Pharmaceutical compositions comprising a proton pump inhibitor, one or
more buffering agent and a prokinetic agent are described. Methods are
described for treating gastric acid related disorders, using
pharmaceutical compositions comprising a proton pump inhibitor, a
buffering agent, and a prokinetic agent.